Reagan-Udall Foundation for the Food and Drug Administration

Analysis

Reagan-Udall Foundation for the Food and Drug Administration is a registered charity in United States, based in Washington, DC. It received its IRS tax-exemption ruling in March 2009, 17 years ago. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Reagan-Udall Foundation for the Food and Drug Administration reported income of $8.2m and spending of $7.8m, spending 95% of its income. Across the 5 years on record, from December 2019 to December 2023, income grew from $2.8m to $8.2m (+196%), an average of +31% a year. The sharpest change came in the year to December 2020, when income rose by 75%. Over the whole period it spent 96% of the income it received.

Among 72,936 United States charities whose main cause is other charitable purposes and that reported income, Reagan-Udall Foundation for the Food and Drug Administration sits at the 94th percentile: it is larger than about 94% of them. Against every charity in United States with reported income it ranks in the 94th percentile, and in the 85th percentile within DC. Charities of a similar size with the same main cause include Manufacturing Institute ($8.2m), Ascension Living-Lakeshore at Siena Inc ($8.2m) and Highfields Inc ($8.2m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 57% and program service revenue 41% of the total. Compensation of current officers, directors and key employees was $686k (8.8% of expenses). Other salaries and wages came to $1.6m. At year end it held assets of $6.4m against liabilities of $2.2m, net assets of $4.2m. It reported 19 employees.